Overview

• On May 30, HHS informed NIH it would end support for multiple HIV vaccine programs, including a $258 million consortium led by Duke and Scripps.
• The administration’s budget rule change forces multi-year NIH vaccine grants to count in one fiscal year, effectively blocking new HIV vaccine awards.
• NIH has paused funding for Moderna’s HIV vaccine trial and was directed not to issue new research grants in the next budget cycle.
• The CDC’s HIV prevention division has been closed, suspending domestic initiatives and U.S. contributions to PEPFAR-supported global programs.
• HHS plans a new Administration for a Healthy America to absorb some HIV prevention and treatment roles, but details on its authority and launch date remain unresolved.